Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Cubist_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2013
|
| gptkbp:DificidIndication |
Clostridium difficile-associated diarrhea
|
| gptkbp:focusesOn |
antibiotics
|
| gptkbp:foundedBy |
gptkb:Michael_N._Chang
|
| gptkbp:foundedIn |
2000
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Optimer Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Dificid
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:OPTR
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:Henry_A._McKinnell
|
| gptkbp:bfsLayer |
6
|